ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014